Psychosomatic disorders (distress, depression, anxiety, somatization) in young patients who have had COVID-19

Abstract

AIM: The mission is to assess possible psychosomatic disorders (in particular, stress as a nervous breakdown, an acute temporal phase of a specific disorder, which is manifested primarily by signs of depression and neurosis) in young patients who have had COVID-19, in the course of rehabilitation, to improve medical and psychological support after their discharge from the hospital.

MATERIALS AND METHODS: 60 convalescents who have had COVID-19 and had practically been healthy before (men aged 19.87 ± 1.64 years) were examined. The main clinical variants and manifestations of COVID-19 in our study were inapparent infection (II) — in 19 cases (31.67%), acute respiratory viral infection (ARVI) — in 21 cases (35.0%), pneumonia without respiratory failure (P) — in 20 cases (33.33%). These are clinical variants and manifestations of mild-to-moderate of COVID-19 severity. The diagnosis of all clinical variants and manifestations of COVID-19, the patients’ examination, treatment and discharge from the hospital were carried out in accordance with regulatory documents. The patients were examined 6–8 month after discharge from the hospital. Psychometric examination of these individuals to separate their clinical manifestations of distress and somatization and manifestations of depression and anxiety was carried out according to the questionnaire “The Four-Dimensional Symptom Questionnaire”, 4DSQ), developed in 1996 by the Dutch specialists B. Terluin. This questionnaire was translation into Russian and adapted by A.B. Smulevich et al. [2014]. Voluntary informed consent was obtained from each of the patients before their participating the study.

RESULTS: Indicators of distress, anxiety, somatization after all the clinical variants and manifestations of COVID-19 have a moderately increased level, which indicates a serious illness that has been suffered, in some cases with an unfavorable outcome. The strongly increased level of depression in our study is probably due to the presence of astheno-neurotic syndrome due to the previous COVID-19 disease. The data on the correlation between the scales of methods indicate the direction of possible psychoprophylactic work with convalescents.

CONCLUSIONS: The results of the study showed that young patients without concomitant diseases who have had COVID-19, even with a mild and low-symptom course, may develop psychosomatic consequences such as distress, anxiety, somatization and some others. The reasons, duration, potential risk factors for their development require further study, however, timely developed preventive and therapeutic and diagnostic measures, taking into account the individual characteristics of the patient, can have a positive effect.

Keywords

COVID-19 / young patients / psychosomatic disorders / 4DSQ questionnaire / distress / depression / anxiety / somatization / rehabilitation

References

[1] Temporary guidelines: prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 11 (07.05.2021). Moscow; 2021. (In Russ.)

[2] Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 11 (07.05.2021). Москва: МЗ РФ, 2021.

[3] Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020;33(2):e100213. DOI: 10.1136/gpsych-2020-100213

[4] Qiu J., Shen B., Zhao M. et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations // Gen. Psychiatr. 2020. Vol. 33, No. 2. P. e100213. DOI: 10.1136/gpsych-2020-100213

[5] Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. DOI: 10.1016/S0140-6736(20)30460-8

[6] Brooks S.K., Webster R.K., Smith L.E. et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence // Lancet. 2020. Vol. 395, No. 10227. P. 912–920. DOI: 10.1016/S0140-6736(20)30460-8

[7] Sokol AF, Shurupova RV. Information fatigue syndrome: ways and methods of its prevention. Acmeology. 2017;(1(61)):116–118. (In Russ.)

[8] Сокол А.Ф., Шурупова Р.В. Синдром информационной усталости: пути и методы его предупреждения // Акмеология. 2017. № 1(61). С. 116–118.

[9] Yang Y, Li W, Zhang Q, et al. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry. 2020;7(4):e19. DOI: 10.1016/s2215-0366(20)30079-1

[10] Yang Y., Li W., Zhang Q. et al. Mental health services for older adults in China during the COVID-19 outbreak // Lancet Psychiatry. 2020. Vol. 7, No. 4. P. e19. DOI: 10.1016/s2215-0366(20)30079-1

[11] Fagiolini A, Cuomo A, Frank E. COVID-19 Diary from a Psychiatry Department in Italy. J Clin Psychiatry. 2020;81(3):20com13357. DOI: 10.4088/JCP.20com13357

[12] Fagiolini A., Cuomo A., Frank E. COVID-19 Diary from a Psychiatry Department in Italy // J. Clin. Psychiatry. 2020. Vol. 81, No. 3. P. 20com13357. DOI: 10.4088/JCP.20com13357

[13] Tubbs AS, Perlis ML, Basner M, et al. Relationship of nocturnal wakefulness to suicide risk across months and methods of suicide. J Clin Psychiatry. 2020;81(2):19m12964. DOI: 10.4088/JCP.19m12964

[14] Tubbs A.S., Perlis M.L., Basner M. et al. Relationship of nocturnal wakefulness to suicide risk across months and methods of suicide // J. Clin. Psychiatry. 2020. Vol. 81, No. 2. P. 19m12964. DOI: 10.4088/JCP.19m12964

[15] Courtet P, Olié E, Debien C, Vaiva G. Keep socially (but not physically) connected and carry on: preventing suicide in the age of COVID-19. J Clin Psychiatry. 2020;81(3):20com13370. DOI: 10.4088/JCP.20com13370

[16] Courtet P., Olié E., Debien C., Vaiva G. Keep socially (but not physically) connected and carry on: preventing suicide in the age of COVID-19 // J. Clin. Psychiatry. 2020. Vol. 81, No. 3. P. 20com13370. DOI: 10.4088/JCP.20com13370

[17] Goldberg JF. Psychiatry’s Niche role in the COVID-19 pandemic. J Clin Psychiatry. 2020;81(3):20com13363. DOI: 10.4088/JCP.20com13363

[18] Goldberg J.F. Psychiatry’s Niche role in the COVID-19 pandemic // J. Clin. Psychiatry. 2020. Vol. 81, No. 3. P. 20com13363. DOI: 10.4088/JCP.20com13363

[19] Goyal K, Chauhan P, Chhikara K, et al. Fear of COVID 2019: First suicidal case in India! Asian J Psychiatr. 2020;49:101989. DOI: 10.1016/j.ajp.2020.101989

[20] Goyal K., Chauhan P., Chhikara K. et al. Fear of COVID 2019: First suicidal case in India! // Asian J. Psychiatr. 2020. Vol. 49. P. 101989. DOI: 10.1016/j.ajp.2020.101989

[21] Goërtz YMJ, van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–2020. DOI: 10.1183/23120541.00542-2020

[22] Goërtz Y.M.J., van Herck M., Delbressine J.M. et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? // ERJ Open Res. 2020. Vol. 6, No. 4. P. 00542–2020. DOI: 10.1183/23120541.00542-2020

[23] Nabavi N. Long COVID: How to define it and how to manage it. BMJ. 2020;370:m3489. DOI: 10.1136/bmj.m3489

[24] Nabavi N. Long covid: How to define it and how to manage it // BMJ. 2020. Vol. 370. P. m3489. DOI: 10.1136/bmj.m3489

[25] Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med. 2007;69(9):860–863. DOI: 10.1097/PSY.0b013e31815b0103

[26] Lieb R., Meinlschmidt G., Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update // Psychosom. Med. 2007. Vol. 69, No. 9. P. 860–863. DOI: 10.1097/PSY.0b013e31815b0103

[27] Barlow DH, Blanchard EB, Vermilyea JA, et al. Generalized anxiety and generalized anxiety disorder: description and reconceptualization. Am J Psychiatry. 1986;143(1):40–44. DOI: 10.1176/ajp.143.1.40

[28] Barlow D.H., Blanchard E.B., Vermilyea J.A. et al. Generalized anxiety and generalized anxiety disorder: description and reconceptualization // Am. J. Psychiatry. 1986. Vol. 143, No. 1. P. 40–44. DOI: 10.1176/ajp.143.1.40

[29] Terluin B, van Marwijk HWJ, Adèr HJ, et al. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry. 2006;6:34. DOI: 10.1186/1471-244X-6-34

[30] Terluin B., van Marwijk H.W.J., Adèr H.J. et al. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization // BMC Psychiatry. 2006. Vol. 6. P. 34. DOI: 10.1186/1471-244X-6-34

[31] Smulevich AB, Yakhno NN, Terluin B, et al. the four-dimensional symptom questionnaire (4DSQ) to assess distress, depression, anxiety and somatization in autonomic and borderline psychosomatic disorders. Korsakov Journal of Neurology and Psychiatry. 2014;114(11):60–66. (In Russ.)

[32] Смулевич A.Б., Яхно Н.Н., Терлуин Б. и др. Возможности применения русскоязычного четырехмерного опросника для оценки дистресса, депрессии, тревоги и соматизации (4ДДТС) при психосоматических расстройствах пограничного уровня // Журнал неврологии и психиатрии им. С.С. Корсакова. 2014. Т. 114, № 11. С. 60–66.

[33] Czachowski S, Terluin B, Izdebski A, Izdebski P. Evaluating the crosscultural validity of the Polish version of the Four-Dimensional Symptom Questionnaire (4DSQ) using differential item functioning (DIF) analysis. Fam Pract. 2012;29(5):609–615. DOI: 10.1093/fampra/cms016

[34] Czachowski S., Terluin B., Izdebski A., Izdebski P. Evaluating the crosscultural validity of the Polish version of the Four-Dimensional Symptom Questionnaire (4DSQ) using differential item functioning (DIF) analysis // Fam. Pract. 2012. Vol. 29, No. 5. P. 609–615. DOI: 10.1093/fampra/cms016

[35] Tebbe BB, Terluin B, Koelewijn JM. Assessing psychological health in midwifery practice: a validation study of the Four-Dimensional Symptom Questionnaire (4DSQ), a Dutch primary care instrument. Midwifery. 2013;29(6):608–615. DOI: 10.1016/j.midw.2012.05.004

[36] Tebbe B.B., Terluin B., Koelewijn J.M. Assessing psychological health in midwifery practice: a validation study of the Four-Dimensional Symptom Questionnaire (4DSQ), a Dutch primary care instrument // Midwifery. 2013. Vol. 29, No. 6. P. 608–615. DOI: 10.1016/j.midw.2012.05.004

[37] Yakhno NN, Parfenov VA, Reyhart DV, et al. The multicenter non-interventional, prospective observational program on the study of practical use of teraligen in patients diagnosed with autonomic disorder (START2: a local Russian experience with the use of the Russian version of The Four-Dimensional Symptom Questionnaire (4DSQ). An intermediate analysis. Korsakov Journal of Neurology and Psychiatry. 2015;115(5):27–33. (In Russ.) DOI: 10.17116/jnevro20151155127-33

[38] Яхно Н.Н., Парфенов В.А., Рейхарт Д.В. и др. Многоцентровая неинтервенционная проспективная наблюдательная программа изучения практики назначения препарата тералиджен у больных с диагнозом вегетативного расстройства (СТАРТ-2: российский опыт применения русскоязычной валидированной версии опросника 4DSQ. Промежуточный анализ) // Журнал неврологии и психиатрии им. С.С. Корсакова. 2015. Т. 115, № 5. С. 27–33. DOI: 10.17116/jnevro20151155127-33

[39] Mendelevich VD, Solov’eva SL. Nevrozologiya i psikhosomaticheskaya meditsina [Nevrozology and psychosomatic medicine]. Moscow; 2002. (In Russ.)

[40] Менделевич В.Д., Соловьева С.Л. Неврозология и психосоматическая медицина. Москва, 2002.

[41] Sobennikov VS, Belyalov FI. Somatization and psychosomatic frustration. Irkutsk; 2010. (In Russ.)

[42] Собенников В.С., Белялов Ф.И. Соматизация и психосоматические расстройства. Иркутск, 2010.

[43] Vorobyova OV. Paradoxes of clinical symptoms and diagnostic criteria of anxiety disorders. Effective Pharmacotherapy. 2014;31:12–19. (In Russ.)

[44] Воробьева О.В. Парадоксы клинических проявлений и диагностических критериев тревожных расстройств // Эффективная фармакотерапия. 2014. № 31. С. 12–19.

[45] Psychosomatic disorders in clinical practice. Moscow; 2019. (In Russ.)

[46] Психосоматические расстройства в клинической практике. Москва, 2019.

[47] Arnautov VS, Reyhart DV, Smulevich AB, et al. The linguistic validation of Russian version of Dutch four-dimensional symptoms questionnaire (4DSQ) for assessing distress, depression, anxiety and somatization in patients with borderline psychosomatic disorders. BMC Res Notes. 2015;8:770. DOI: 10.1186/s13104-015-1766-8

[48] Arnautov V.S., Reyhart D.V., Smulevich A.B. et al. The linguistic validation of Russian version of Dutch four-dimensional symptoms questionnaire (4DSQ) for assessing distress, depression, anxiety and somatization in patients with borderline psychosomatic disorders // BMC Res. Notes. 2015. Vol. 8. P. 770. DOI: 10.1186/s13104-015-1766-8

[49] Verkuil B, Brosschot JF, Meerman EE, Thayer JF. Effects of momentary assessed stressful events and worry episodes on somatic health complaints. Psychol Health. 2012;27(2):141–158. DOI: 10.1080/08870441003653470

[50] Verkuil B., Brosschot J.F., Meerman E.E., Thayer J.F. Effects of momentary assessed stressful events and worry episodes on somatic health complaints // Psychol. Health. 2012. Vol. 27, No. 2. P. 141–158. DOI: 10.1080/08870441003653470

[51] Golovacheva VA, Parfenov VA. How to help patients diagnosed with “vegetovascular dystonia”? Consilium Medicum (Neurology and Rheumatology). 2017;19(2.2):19–26. (In Russ.)

[52] Головачева В.А., Парфенов В.А. Как помочь пациентам с диагнозом «вегетососудистая дистония»? // Consilium Medicum (Неврология и Ревматология). 2017. Т. 19, № 2.2. С. 19–26.

[53] Ivashkin VT, Okhlobystina OZ, Mayevskaya MV, et al. Dynamics of somatic and comorbid mental disorders (distress, anxiety, somatisation and depression) in patients with irritable bowel syndrome during therapy with alimemazine: results of an non-interventional observational programme (“Terra”). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(6):38–50. (In Russ.) DOI: 10.22416/1382-4376-2018-28-6-38-50

[54] Ивашкин В.Т., Охлобыстина О.З., Маевская М.В. и др. Динамика соматических и коморбидных психических расстройств (дистресса, тревоги, соматизации и депрессии) у пациентов с синдромом раздраженного кишечника на фоне терапии алимемазином: результаты неинтервенционной наблюдательной программы («TERRA») // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018. Т. 28, №. 6. С.38–50. DOI: 10.22416/1382-4376-2018-28-6-38-50

[55] Gillies RR, Chenok KE, Shortell SM, et al. The impact of health plan delivery system organization on clinical quality and patient satisfaction. Health Serv Res. 2006;41(4 Pt 1):1181–1199. DOI: 10.1111/j.1475-6773.2006.00529.x

[56] Gillies R.R., Chenok K.E., Shortell S.M. et al. The impact of health plan delivery system organization on clinical quality and patient satisfaction // Health Serv. Res. 2006. Vol. 41, No. 4 Pt 1. P. 1181–1199. DOI: 10.1111/j.1475-6773.2006.00529.x

[57] Belyalov FI. Mental disorders in the practice of a therapist. 6th ed. Irkutsk; 2014. (In Russ.)

[58] Белялов Ф.И. Психические расстройства в практике терапевта. 6-е изд., перераб. и доп. Иркутск, 2014.

[59] Psychometric Testing: New Studies. Counseling Psychology and Psychotherapy. 2018;26(3(101)):191–203. (In Russ.) DOI: 10.17759/cpp.2018260310

[60] Психометрические тесты: новые исследования // Консультативная психология и психотерапия. 2018. Т. 26, № 3(101). С. 191–203. DOI: 10.17759/cpp.2018260310

[61] Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. DOI: 10.1038/s41586-020-2008-3

[62] Wu F., Zhao S., Yu B. et al. A new coronavirus associated with human respiratory disease in China // Nature. 2020. Vol. 579, No. 7798. P. 265–269. DOI: 10.1038/s41586-020-2008-3

[63] Voronov VM. The COVID-19 pandemic as an existential and cultural event: groups, new cultural boundaries, and the phenomenon of mood (a case study of the russian society). Journal of Frontier Studies. 2021;6(1(21)):41–68. (In Russ.) DOI: 10.465319/jfs.v6i1.274

[64] Воронов В.М. Пандемия COVID-19 как экзистенциальное и культурное событие: группы, культурные границы и феномен настроения (на примере российского общества) // Журнал фронтирных исследований. 2021. Т. 6, № 1(21). С. 41–68. DOI: 10.465319/jfs.v6i1.274

[65] Graichen H. What is the difference between the first and the second/third wave of COVID-19? – German perspective. J Orthop. 2021;24:A1–A3. DOI: 10.1016/j.jor.2021.01.011

[66] Graichen H. What is the difference between the first and the second/third wave of COVID-19? – German perspective // J. Orthop. 2021. Vol. 24. P. A1–A3. DOI: 10.1016/j.jor.2021.01.011

RIGHTS & PERMISSIONS

Ulyukin I.M., Kiseleva N.V., Rassokhin V.V., Orlova E.S., Sechin A.A.